alendronate sodium trihydrate Tablets, film coated 91.35 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years.
Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders.
The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture.
Regularity team prepares EU CTD format document.
Manufacturer usually replies in 32 days
None